# Evaluation of Amniotic Fluid Product in Knee Osteoarthritis

> **NCT02768155** · NA · COMPLETED · sponsor: **MiMedx Group, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **OTHER:** Amniotic Fluid 4.0ml dose
- **OTHER:** Amniotic Fluid 2.0ml dose
- **OTHER:** Placebo Control

## Key facts

- **NCT ID:** NCT02768155
- **Lead sponsor:** MiMedx Group, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2017-04
- **Final completion:** 2017-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02768155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02768155, "Evaluation of Amniotic Fluid Product in Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT02768155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*